1. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
   Roberto Mattioli et al, 2023, Molecular Aspects of Medicine CrossRef
2. The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
   Sepideh Mirzaei et al, 2021, European Journal of Pharmacology CrossRef
3. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells’ Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers
   Sara R. Martins-Neves et al, 2023, International Journal of Molecular Sciences CrossRef
4. The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
   Riris Istighfari Jenie et al, 2018, Advanced Pharmaceutical Bulletin CrossRef
5. MicroRNA-34a inhibits epithelial-mesenchymal transition of lens epithelial cells by targeting Notch1
   Ruifang Han et al, 2019, Experimental Eye Research CrossRef
6. Advances in anti-cancer effects and underlying mechanisms of marine algae polysaccharides
   Wanzi Yao et al, 2022, International Journal of Biological Macromolecules CrossRef
7. Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor
   Guannan Zhao et al, 2019, Molecular Cancer Therapeutics CrossRef
8. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
   Óscar Estupiñán et al, 2023, Biomedicine & Pharmacotherapy CrossRef
9. The exocyst complex regulates C. elegans germline stem cell proliferation by controlling membrane Notch levels
   Kumari Pushpa et al, 2021, Development CrossRef
10. Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma
    Chongchong Wang et al, 2018, Investigational New Drugs CrossRef
11. Velvet Antler compounds targeting major cell signaling pathways in osteosarcoma - a new insight into mediating the process of invasion and metastasis in OS
    Zhengyao Zhang et al, 2019, Open Chemistry CrossRef
12. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
    Nadezda Zhdanovskaya et al, 2021, Cancers CrossRef
13. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma
    Guo Dai et al, 2021, European Journal of Pharmacology CrossRef
14. Drug resistance in gynecologic cancers: Emphasis on noncoding RNAs and drug efflux mechanisms
    Rama Rao Malla et al, 2021, Overcoming Drug Resistance in Gynecologic Cancers CrossRef